Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes.

OBJECTIVES: The purpose of this study was to investigate the relationship between hepatic triglyceride content and both myocardial function and metabolism in type 2 diabetes mellitus (T2DM). BACKGROUND: Heart disease is the leading cause of mortality in T2DM. Central obesity and hepatic steatosis, both hallmark abnormalities in T2DM, have been related to increased risk of heart disease. METHODS: Sixty-one T2DM patients underwent myocardial perfusion and substrate metabolism measurements by positron emission tomography, using [15O]water, [11C]palmitate, and [18F]-2-fluoro-2-deoxy-D-glucose. In addition, whole-body insulin sensitivity (M/I) was determined. Myocardial left ventricular function and high-energy phosphate metabolism were measured using magnetic resonance imaging and [31P]-magnetic resonance spectroscopy, respectively. Hepatic triglyceride content was measured by proton magnetic resonance spectroscopy. Patients were divided according to hepatic triglyceride content (T2DM-low5.56%). RESULTS: In addition to decreased M/I (p=0.002), T2DM-high patients had reduced myocardial perfusion (p=0.001), glucose uptake (p=0.005), and phosphocreatine/adenosine triphosphate (PCr/ATP) ratio (p=0.003), compared with T2DM-low patients, whereas cardiac fatty acid metabolism and left ventricular function were not different. Hepatic triglyceride content correlated inversely with M/I (Pearson's r=-0.620, p<0.001), myocardial glucose uptake (r=-0.413, p=0.001), and PCr/ATP (r=-0.442, p=0.027). Insulin sensitivity correlated positively with myocardial glucose uptake (r=0.528, p<0.001) and borderline with myocardial PCr/ATP (r=0.367, p=0.072), whereas a positive association was found between cardiac glucose uptake and PCr/ATP (r=0.481, p=0.015). CONCLUSIONS: High liver triglyceride content in T2DM was associated with decreased myocardial perfusion, glucose uptake, and high-energy phosphate metabolism in conjunction with impaired M/I. The long-term clinical implications of hepatic steatosis with respect to cardiac metabolism and function in the course of T2DM require further study.